230 related articles for article (PubMed ID: 32527797)
1. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model.
Pantalone KM; Misra-Hebert AD; Hobbs TM; Kong SX; Ji X; Ganguly R; Milinovich A; Weng W; Bauman JM; Petraro P; Burguera B; Zimmerman RS; Kattan MW
Diabetes Care; 2020 Aug; 43(8):1910-1919. PubMed ID: 32527797
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Outcomes After Initiating Triple Antidiabetic Therapy with a GLP-1 RA in an Integrated Health Care System.
Lee SM; Aboubechara N; Niu F; Ledesma VM; Patel YA; Millares M; Hui RL
J Manag Care Spec Pharm; 2019 Mar; 25(3):350-356. PubMed ID: 30816819
[TBL] [Abstract][Full Text] [Related]
3. Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting.
Kallenbach L; Shui AM; Cheng WY; Fan T; Hu W; Zichlin ML; Duh MS; Ye F; Levin PA
Endocr Pract; 2018 Sep; 24(9):805-814. PubMed ID: 29975575
[TBL] [Abstract][Full Text] [Related]
4. Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
Pantalone KM; Wells BJ; Chagin KM; Ejzykowicz F; Yu C; Milinovich A; Bauman JM; Kattan MW; Rajpathak S; Zimmerman RS
Diabetes Care; 2016 Sep; 39(9):1527-34. PubMed ID: 27519447
[TBL] [Abstract][Full Text] [Related]
5. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.
Riedel AA; Heien H; Wogen J; Plauschinat CA
Pharmacotherapy; 2007 Aug; 27(8):1102-10. PubMed ID: 17655510
[TBL] [Abstract][Full Text] [Related]
6. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
[TBL] [Abstract][Full Text] [Related]
7. Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.
Riedel AA; Heien H; Wogen J; Plauschinat CA
Am J Manag Care; 2007 Aug; 13(8):457-63. PubMed ID: 17685826
[TBL] [Abstract][Full Text] [Related]
8. Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015.
Misra-Hebert AD; Pantalone KM; Ji X; Milinovich A; Dey T; Chagin KM; Bauman JM; Kattan MW; Zimmerman RS
Diabetes Care; 2018 Jun; 41(6):1164-1171. PubMed ID: 29549082
[TBL] [Abstract][Full Text] [Related]
9. "Act on Threes" Paradigm for Treatment Intensification of Type 2 Diabetes in Managed Care: Results of a Randomized Controlled Study with an Educational Intervention Targeting Improved Glycemic Control.
Bieszk N; Reynolds SL; Wei W; Davis C; Kamble P; Uribe C
J Manag Care Spec Pharm; 2016 Sep; 22(9):1028-38. PubMed ID: 27579824
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home.
Prudencio J; Cutler T; Roberts S; Marin S; Wilson M
J Manag Care Spec Pharm; 2018 May; 24(5):423-429. PubMed ID: 29694290
[TBL] [Abstract][Full Text] [Related]
11. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
Rajpathak SN; Rajgopalan S; Engel SS
J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
[TBL] [Abstract][Full Text] [Related]
12. Quality measure attainment in patients with type 2 diabetes mellitus.
Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Sheng Duh M; Lefebvre P
Am J Manag Care; 2014 Jan; 20(1 Suppl):s5-15. PubMed ID: 24512194
[TBL] [Abstract][Full Text] [Related]
13. Medication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 Diabetes.
Yeh A; Shah-Manek B; Lor KB
Ann Pharmacother; 2017 Feb; 51(2):111-117. PubMed ID: 28042735
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Attainment of Glycemic Targets Among Adults With Type 1 and Type 2 Diabetes in Canada: A Cross-sectional Study Using Primary and Specialty Care Electronic Medical Record Data.
Weisman A; Brown R; Chu L; Aronson R; Perkins BA
Can J Diabetes; 2024 Feb; 48(1):44-52.e5. PubMed ID: 37717631
[TBL] [Abstract][Full Text] [Related]
15. Canagliflozin treatment of Hispanic and non-Hispanic patients with type 2 diabetes in a US managed care setting.
Chow W; Buysman E; Rupnow MF; Aguilar R; Henk HJ
Curr Med Res Opin; 2016; 32(1):13-22. PubMed ID: 26414434
[TBL] [Abstract][Full Text] [Related]
16. Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes.
Lin SD; Tsai ST; Tu ST; Su CC; Chen JF; Lu CH; Wang CH; Yu NC; Hsu SR; Hsieh MC
Prim Care Diabetes; 2015 Apr; 9(2):135-41. PubMed ID: 25266893
[TBL] [Abstract][Full Text] [Related]
17. Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study.
Ke C; Stukel TA; Shah BR; Lau E; Ma RC; So WY; Kong AP; Chow E; Chan JCN; Luk A
PLoS Med; 2020 Sep; 17(9):e1003316. PubMed ID: 32946450
[TBL] [Abstract][Full Text] [Related]
18. Intensification patterns and the probability of HbA
Pantalone KM; Misra-Hebert AD; Hobbs TM; Ji X; Kong SX; Milinovich A; Weng W; Bauman JM; Ganguly R; Burguera B; Kattan MW; Zimmerman RS
Diabet Med; 2020 Jul; 37(7):1114-1124. PubMed ID: 30653705
[TBL] [Abstract][Full Text] [Related]
19. Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910-1919.
Larroumet A; Foussard N; Monlun M; Blanco L; Mohammedi K; Rigalleau V
Diabetes Care; 2020 Dec; 43(12):e198. PubMed ID: 33218982
[No Abstract] [Full Text] [Related]
20. Response to Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910-1919.
Pantalone KM; Misra-Hebert AD; Burguera B; Kattan MW
Diabetes Care; 2020 Dec; 43(12):e199. PubMed ID: 33218983
[No Abstract] [Full Text] [Related]
[Next] [New Search]
